Biotech & Health Extension

sponsored by 100 Plus Capital

A group of scientists, entrepreneurs, funders, and institutional allies who cooperate to advance biotechnology to reverse aging, extend human healthspans, and improve cognition. Meetings are private and may be off the record. Those that are recorded can be found below.
 
This group is sponsored by 100 Plus Capital. 100 Plus Capital invests in companies positively impacting human longevity. This can be directly targeted (for example, anti-aging companies) or broader reaching (clean food and water companies).
Apply to join

UPCOMING PROGRAM

SEMINAR SUMMARIES

Recordings, written summaries and slides of previous keynotes

Mechanisms of longevity Lessons from Long-Lived Mammals
Vera Gorbunova, University of Rochester
Seminar Summary >

Cryonics Sign-Up Q&A + Demo
Emil Kendziorra, Max More
Seminar Summary >

Hormesis for Healthy Aging and Longevity
Suresh Rattan, Aarhus University
Seminar Summary >

Autophagy and Neurodegeneration
David Rubinsztein, Cambridge
Seminar Summary >

Women’s Health and Longevity
Maila Reeves, Dr. Stephanie Manson-Brown, Claudia Von Boeselager, Nikolina Lauc
Off the record
Seminar Summary >

Aging: Understanding it, Reversing it
Michael Fossel, Telocyte
Seminar Summary >

Investor Q&A
Sonia Arrison, 100 Plus Capital
Off the record
Seminar Summary >

Longevity Policy Opportunities
Dylan Livingston, Alliance for Longevity Initiatives
Seminar Summary >

From nanotech to living sensors
Clarice D. Aiello
Seminar Summary >

Policy Focus
Dylan Livingston, Alliance for Longevity Initiatives
Joe DeSantis
Seminar Summary >

Longevity & Deep Tech Investor Q&A
Christian Angermayer, Rejuveron
Seminar Summary >

Epigenetic Reprogramming of Aging
Vittorio Sebastiano, Stanford University
Seminar Summary >

Dylan Livingston, Alliance for Longevity Initiatives | Longevity Policy Focus
Seminar Summary >

2022 Group Launch | Your Biotech Goals
Seminar Summary >

Longevity Investor Q&A Karl Pfleger, Agingbiotech.info
Seminar Summary >

Progress on Health Extension in 2021
Sonia Arrison, 100 Plus Capital
Seminar Summary >

Q&A on How to Fight Aging
Reason, Fight Aging
Seminar Summary >

Longevity Investing
Sergey Young, Longevity Vision Fund
Neil Littman, Bioverge
Seminar Summary >

Building a pipeline of clinical-stage therapies to target aging
Kristen Fortney, Bioage
Seminar Summary >

Systems Immunology of Aging to ​Enable Precision Preventative Medicine
David Furman, Buck Institute
Seminar Summary >

Atherosclerosis: The As Yet Undefeated Monster
Reason, Fight Aging
Seminar Summary >

Biostasis & Cryonics Q&A
Emil Kendziorra
Aschwin De Wolf
Seminar Summary >

Biohacking – A necessary component of a strategy for radical life extension
Alexander Fedintsev, lifespan.io
Seminar Summary >

The DunedinPoAm DNA Methylation Algorithm
Daniel Belsky, Columbia University
Terrie Moffitt, Duke University.
Seminar Summary >

Monitoring Personal Health and Ageotypes Using Big Data
Michael Snyder, Stanford University
Seminar Summary >

Bioelectric Networks: Taming the Collective Intelligence of Cells for Regenerative Medicine
Michael Levin, Tufts Center for Regenerative and Developmental Biology
Seminar Summary >

Drug Target Discovery for Cellular Rejuvenation by ‘Driver’ Clocks
Daniel Ives, Shift Bioscience
Seminar Summary >

TAME Q&A: Lessons for Progress on Aging
Nir Barzilai, Albert Einstein School of Medicine
Seminar Summary >

Patient Trials in a Dish” Paths Forward
Keith Murphy, Organovo, Viscient Biosciences
David Gobel, Methuselah Foundationt
Seminar Summary >

Biomarker Standardization
Morgan Levine, Yale
Jamie Justice, Wake Forest
Seminar Summary >

EpigeneticClocks: What’s New & What’s Missing?
Steve Horvath, UCLA
Seminar Summary >

Biomarker & Aging Clock Development
Vadim Gladyshev, Harvard
Gordan Lauc, GlycanAge
Seminar Summary >

Longevity as a Service: AI & Aging Clocks
Alex Zhavoronkov, Deep Longevity & Insilico Medicine
Seminar Summary >

ALARMA (America’s Longevity, Aging and Regenerative Medicine Association)
Dylan Livingston, ALARMA
Seminar Summary >

Thymus Rejuvenation Progress Update
Greg Fahy, Intervene Immune
Seminar Summary >

Biomarkers and Drug Development: Regulatory Perspective
Christopher Leptak, CDER Biomarker Qualification Program, FDA
Seminar Summary >

How to Fund and Build Geroprotectors
James Peyer, Cambrian Biopharma
Seminar Summary >

Institutional perspective: What work could dramatically advance progress on aging from an NIA perspective?
Ronald Kohanski, National Institute on Aging
Seminar Summary >

Clinical Trials & Senolytics Q&A
James Kirkland, Mayo Clinic
Seminar Summary >

Brain Cell Replacement as the Cornerstone to Beating Aging
Jean Hebert, Albert Einstein School of Medicine
Seminar Summary >

Brian Kennedy, Buck Institute
Joris Deelen, Max Planck Institute for Aeging
Lynne Cox, Oxford University
Underincentivized Basic Research In Health Extension
View keynote summary >

     

Underincentivized Basic Research In Health Extension
Brian Kennedy, Buck Institute
Joris Deelen, Max Planck Institute for Aeging
Lynne Cox, Oxford University
Seminar Summary >

Tissue Rejuvenation via Plasma Dilution
Irina Conboy, UC Berkeley
Seminar Summary >

Sonia Arrison, 100 Plus Capital
Karl Pfleger, Agingbiotech.info
Mike West, AgeX
Industry Blindspots for Dramatically Advancing Progress in Health Extension
View keynote summary >

Industry Blindspots for Dramatically Advancing Progress in Health Extension
Sonia Arrison, 100 Plus Capital
Karl Pfleger, Agingbiotech.info
Mike West, AgeX
Seminar Summary >

Allison Duettmann, Foresight Institute
Sonia Arrison, 100 Plus Capital
Define 2021 Goals
View keynote summary >

Define 2021 Goals
Allison Duettmann, Foresight Institute
Sonia Arrison, 100 Plus Capital
Seminar Summary >